Tapewire

NYSE · USD

CSW

CSW INDUSTRIALS, INC.

Export transactions ↓
Tapewire entity
3917
SEC CIK
0001624794
Parsed reports
426

Last 12 months

Inside the activity.

1 purchase rows · 23 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202505
Jan 202602
Feb 202602
Mar 202611
Apr 202603
May 202602
Jun 202601
Jul 202601
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 29, 2024 Filed May 30, 2024 23:41 UTC GrantPerformance Rights · Derivative 1,866 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000041 · wk-form4_1717112468.xml · derivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,866

Underlying: Common Stock · 1,866 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
May 29, 2024 Filed May 30, 2024 23:37 UTC
Sullivan DonEVP, Chief Strategy Officer
GrantPerformance Rights · Derivative 1,790 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000037 · wk-form4_1717112234.xml · derivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,790

Underlying: Common Stock · 1,790 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
May 28, 2024 Filed May 30, 2024 19:40 UTC GiftCommon Stock 40 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000040 · wk-form4_1717112417.xml · nonDerivative · entry 1

Sweezey Jay Kent · CIK 0001691674 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,326

F1 · kind: On May 28, 2024, the Reporting Person made a charitable gift of 40 shares to a nonprofit organization for which no payment or consideration was received by the Reporting Person.

F1 · price: On May 28, 2024, the Reporting Person made a charitable gift of 40 shares to a nonprofit organization for which no payment or consideration was received by the Reporting Person.

Read SEC document
April 17, 2024 Filed Apr 18, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 18 $235.23 $4,234.14
Disclosure

SEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 7

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,579

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.17 to $235.425, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 17, 2024 Filed Apr 18, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 106 $234.59 $24,866.54
Disclosure

SEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,597

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.17 to $235.165, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 17, 2024 Filed Apr 18, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 101 $233.62 $23,595.62
Disclosure

SEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,703

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.17 to $234.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 17, 2024 Filed Apr 18, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 547 $232.60 $127,232.20
Disclosure

SEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,804

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.155 to $233.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 17, 2024 Filed Apr 18, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 180 $231.79 $41,722.20
Disclosure

SEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,351

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.15 to $232.145, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 17, 2024 Filed Apr 18, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 24 $230.37 $5,528.88
Disclosure

SEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,531

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.925 to $230.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 17, 2024 Filed Apr 18, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 24 $229.42 $5,506.08
Disclosure

SEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,555

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.80 to $229.755, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:28 UTC
UNDERWOOD JEFFSVP, GM Contractor Solutions
Exercise / conversionPerformance Rights · Derivative 1,553 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000019 · wk-form4_1712262510.xml · derivative · entry 4

UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,553 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 30 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 30 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 30 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:28 UTC
UNDERWOOD JEFFSVP, GM Contractor Solutions
Tax withholdingCommon Stock 1,265 $231.92 $293,378.80
Disclosure

SEC source: 0001624794-24-000019 · wk-form4_1712262510.xml · nonDerivative · entry 2

UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,321

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:28 UTC
UNDERWOOD JEFFSVP, GM Contractor Solutions
Exercise / conversionCommon Stock 3,166 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000019 · wk-form4_1712262510.xml · nonDerivative · entry 1

UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,586

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:25 UTC
Alverson LukeSVP, GC & Secretary
Exercise / conversionPerformance Rights · Derivative 1,135 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000017 · wk-form4_1712262344.xml · derivative · entry 4

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,135 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:25 UTC
Alverson LukeSVP, GC & Secretary
Tax withholdingCommon Stock 927 $231.92 $214,989.84
Disclosure

SEC source: 0001624794-24-000017 · wk-form4_1712262344.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,307

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:25 UTC
Alverson LukeSVP, GC & Secretary
Exercise / conversionCommon Stock 2,318 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000017 · wk-form4_1712262344.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:24 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionPerformance Rights · Derivative 6,154 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000016 · wk-form4_1712262285.xml · derivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,154 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 97 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 97 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 97 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:24 UTC
Armes Joseph BDirector · Chairman, President & CEO
Tax withholdingCommon Stock 4,920 $231.92 $1,141,046.40
Disclosure

SEC source: 0001624794-24-000016 · wk-form4_1712262285.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,579

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:24 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 12,502 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000016 · wk-form4_1712262285.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:27 UTC Exercise / conversionPerformance Rights · Derivative 2,650 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000018 · wk-form4_1712262429.xml · derivative · entry 4

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,650 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 44 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 44 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 44 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:27 UTC Tax withholdingCommon Stock 2,131 $231.92 $494,221.52
Disclosure

SEC source: 0001624794-24-000018 · wk-form4_1712262429.xml · nonDerivative · entry 2

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,315

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:27 UTC Exercise / conversionCommon Stock 5,388 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000018 · wk-form4_1712262429.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:23 UTC
Sullivan DonEVP, GM Contractor Solutions
Exercise / conversionPerformance Rights · Derivative 3,029 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000015 · wk-form4_1712262178.xml · derivative · entry 4

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,029 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 53 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 53 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 53 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:23 UTC
Sullivan DonEVP, GM Contractor Solutions
Tax withholdingCommon Stock 2,435 $231.92 $564,725.20
Disclosure

SEC source: 0001624794-24-000015 · wk-form4_1712262178.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,685

Read SEC document
April 03, 2024 Filed Apr 4, 2024 20:23 UTC
Sullivan DonEVP, GM Contractor Solutions
Exercise / conversionCommon Stock 6,164 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000015 · wk-form4_1712262178.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,120

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 21:16 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 1,000 $230.06 $230,056.60
Disclosure

SEC source: 0001624794-24-000013 · wk-form4_1710796599.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,997

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 22:07 UTC
Sullivan DonEVP, GM Contractor Solutions
SaleCommon Stock 2,029 $231.59 $469,896.11
Disclosure

SEC source: 0001624794-24-000012 · wk-form4_1710540451.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,956

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.31 to $231.895, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 22:07 UTC
Sullivan DonEVP, GM Contractor Solutions
SaleCommon Stock 5,797 $230.66 $1,337,136.02
Disclosure

SEC source: 0001624794-24-000012 · wk-form4_1710540451.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,985

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.29 to $231.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 21:42 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 263 $233.30 $61,357.90
Disclosure

SEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 7

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,997

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.22 to $233.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 21:42 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 592 $232.54 $137,663.68
Disclosure

SEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,260

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.21 to $233.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 21:42 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 47 $231.73 $10,891.31
Disclosure

SEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,852

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.15 to $232.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 21:42 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 28 $230.59 $6,456.52
Disclosure

SEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,899

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.135 to $231.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 21:42 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 31 $229.37 $7,110.47
Disclosure

SEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,927

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.12 to $229.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 21:42 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 25 $228.07 $5,701.75
Disclosure

SEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,958

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.80 to $228.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 21:42 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 14 $227.21 $3,180.94
Disclosure

SEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,983

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.79 to $227.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 07, 2024 Filed Feb 7, 2024 21:50 UTC
Alverson LukeSVP, GC & Secretary
GiftCommon Stock 433 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000010 · wk-form4_1707342627.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,916

F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 22:35 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 43 $204.55 $8,795.65
Disclosure

SEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,997

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.30 to $205.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 22:35 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 441 $203.76 $89,858.16
Disclosure

SEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,040

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.28 to $204.27, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 22:35 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 200 $202.74 $40,548.00
Disclosure

SEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,481

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.27 to $203.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 22:35 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 173 $201.82 $34,914.86
Disclosure

SEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,681

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.25 to $202.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 22:35 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 117 $200.68 $23,479.56
Disclosure

SEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,854

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.23 to $201.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 22:35 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 26 $199.85 $5,196.10
Disclosure

SEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,971

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.20 to $200.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:12 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 34 $180.44 $6,134.96
Disclosure

SEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,997

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.27 to $180.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:12 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 99 $179.80 $17,800.20
Disclosure

SEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,031

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.27 to $180.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:12 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 104 $178.64 $18,578.56
Disclosure

SEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,130

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.19 to $179.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:12 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 122 $177.18 $21,615.96
Disclosure

SEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,234

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.09 to $178.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:12 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 25 $175.42 $4,385.50
Disclosure

SEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,356

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:12 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 616 $174.69 $107,609.04
Disclosure

SEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,381

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.00 to $174.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 16, 2023 Filed Oct 16, 2023 21:20 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 93 $176.91 $16,452.63
Disclosure

SEC source: 0001624794-23-000096 · wk-form4_1697491247.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,997

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.50 to $177.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 16, 2023 Filed Oct 16, 2023 21:20 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 92 $176.05 $16,196.60
Disclosure

SEC source: 0001624794-23-000096 · wk-form4_1697491247.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,090

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.50 to $176.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.